(Total Views: 645)
Posted On: 09/20/2020 11:50:14 PM
Post# of 148988
A question regarding the market for CV. According to The Worldometers site there are currently 2.5 million active cases in the US. Of those a little over 14,000 are severe/critical.
With the FDA seemingly unimpressed with our CD10 trial results does that potentially limit sales to S/c only?
If I’m interpreting this incorrectly (and I hope I am) please let me know.
With the FDA seemingly unimpressed with our CD10 trial results does that potentially limit sales to S/c only?
If I’m interpreting this incorrectly (and I hope I am) please let me know.
(0)
(0)Scroll down for more posts ▼
